User profiles for Nicolas Casadei

Nicolas Casadei

Head genomics core facility, Group leader Parkinson's disease, Institute of Human Genetics …
Verified email at med.uni-tuebingen.de
Cited by 2805

Swarm learning for decentralized and confidential clinical machine learning

…, S Ktena, F Tran, M Bitzer, S Ossowski, N Casadei… - Nature, 2021 - nature.com
Fast and reliable detection of patients with severe and heterogeneous illnesses is a major
goal of precision medicine 1 , 2 . Patients with leukaemia can be identified using machine …

[PDF][PDF] Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19

…, E Bonifacio, P Bork, B Boyke, H Blum, N Casadei… - Immunity, 2021 - cell.com
Longitudinal analyses of the innate immune system, including the earliest time points, are
essential to understand the immunopathogenesis and clinical course of coronavirus disease (…

[HTML][HTML] Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats

…, H Gram, TW Mikkelsen, AKO Alstrup, N Casadei… - Acta …, 2019 - Springer
The conversion of endogenous alpha-synuclein (asyn) to pathological asyn-enriched
aggregates is a hallmark of Parkinson’s disease (PD). These inclusions can be detected in the …

rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent …

M Oliveras-Salvá, A Van der Perren, N Casadei… - Molecular …, 2013 - Springer
Background Alpha-synuclein is a key protein implicated in the pathogenesis of Parkinson's
disease (PD). It is the main component of the Lewy bodies, a cardinal neuropathological …

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease

…, T Schirinzi, G Sancesario, N Casadei… - Nature …, 2019 - nature.com
Neuroinflammation is one of the hallmarks of Parkinson’s disease (PD) and may contribute
to midbrain dopamine (DA) neuron degeneration. Recent studies link chronic inflammation …

A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats

…, K Schönig, F Zimmermann, C Bauer, N Casadei… - Brain, 2013 - academic.oup.com
Conversion of soluble α-synuclein into insoluble and fibrillar inclusions is a hallmark of
Parkinson’s disease and other synucleinopathies. Accumulating evidence points towards a …

Platelet-derived microRNAs regulate cardiac remodeling after myocardial ischemia

…, M Gawaz, KG Heinze, N Casadei… - Circulation …, 2023 - Am Heart Assoc
Background: Platelets can infiltrate ischemic myocardium and are increasingly recognized as
critical regulators of inflammatory processes during myocardial ischemia and reperfusion (I/…

Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P] αSyn …

M Diepenbroek, N Casadei, H Esmer… - Human molecular …, 2014 - academic.oup.com
Lewy bodies, a pathological hallmark of Parkinson's disease (PD), contain aggregated
alpha-synuclein (αSyn), which is found in several modified forms and can be discovered …

Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral …

…, F Macchi, AS Van Rompuy, S Sarre, N Casadei… - Neurobiology of …, 2015 - Elsevier
Testing of new therapeutic strategies for Parkinson's disease (PD) is currently hampered by
the lack of relevant and reproducible animal models. Here, we developed a robust rat model …

α-Synuclein in Parkinson's disease: causal or bystander?

P Riederer, D Berg, N Casadei, F Cheng… - Journal of neural …, 2019 - Springer
Parkinson’s disease (PD) comprises a spectrum of disorders with differing subtypes, the
vast majority of which share Lewy bodies (LB) as a characteristic pathological hallmark. The …